(S)-5-{3-[4-(4-Chloro-phenyl)-4-hydroxy 3,3-dimethyl-piperidin-1 -yl] -prop- ylidene}-5,11-dihydro-10-oxa-1 -aza dibenzo[a,d] cycloheptene-7-carboxylic acid
PK141070AUndetermined Publication Date: 2011-01-17MILLENNIUM PHARMACEUTICALS INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200300984
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2011-01-17
Abstract
The invention providers compound having the formula: wherein R1 is halogen. The invention also provides composition comprising the compound. The disclosed compound have CCR1 antagonist activity.
Need to check novelty before this filing date? Find Prior Art